$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Use of liposomes in a carrier comprising a continuous hydrophobic phase for delivery of polynucleotides in vivo 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • A61K-009/127
  • A61P-043/00
  • A61K-031/7088
  • C12N-015/88
출원번호 US-0679875 (2008-09-24)
등록번호 US-9498493 (2016-11-22)
국제출원번호 PCT/CA2008/001678 (2008-09-24)
§371/§102 date 20100324 (20100324)
국제공개번호 WO2009/039628 (2009-04-02)
발명자 / 주소
  • Mansour, Marc
  • Karkada, Mohan
  • Weir, Genevieve Mary
출원인 / 주소
  • IMMUNOVACCINE TECHNOLOGIES INC.
대리인 / 주소
    Husch Blackwell LLP
인용정보 피인용 횟수 : 1  인용 특허 : 80

초록

The invention provides compositions comprising a carrier comprising a continuous phase of a hydrophobic substance, liposomes, and a polynucleotide, and methods for using such compositions for delivering a polynucleotide to a subject.

대표청구항

1. An injectable composition comprising: a carrier comprising mannide oleate and a continuous phase of mineral oil;liposomes comprising an unsaturated phospholipid; anda polynucleotide encapsulated within said liposomes, said polynucleotide encoding a polypeptide and being operably linked to a promo

이 특허에 인용된 특허 (80)

  1. Hagen, Michael, Adjuvant combination formulations.
  2. Leesman, Glen D., Adjuvant composition and methods for its use.
  3. Gerber, Jay D., Adjuvant composition for mucosal and injection delivered vaccines.
  4. Haensler, Jean; Trannoy, Emmanuelle; Ronco, Jorge, Adjuvant for a vaccine composition.
  5. Kullenberg Fred W. (Ginger Woods Rd. ; Lot 20 Valley NE 68064), Adjuvant for dose treatment with antigens.
  6. Glenn Gregory M. ; Alving Carl R., Adjuvant for transcutaneous immunization.
  7. Gary Van Nest ; Gary Ott ; Gail Barchfeld, Adjuvant formulation comprising a submicron oil droplet emulsion.
  8. Roberts, David S.; Swearingin, Leroy A.; Dearwester, Don A., Adjuvants for use in vaccines.
  9. Popescu Mircea, Affinity associated vaccine.
  10. Johnson, David A., Amphipathic aldehydes and their uses as adjuvants and immunoeffectors.
  11. Aneja Rajindra, Amphiphilic materials and liposome formulations thereof.
  12. Carlsson, Hans; Larsson, Anette; S?derlind, Erik, Antigen delivery system and method of production.
  13. Bonnet, Dominique; Brown, Carlton B.; Georges, Bertrand; Sizer, Philip J., Antigen delivery vectors and constructs.
  14. Brown,Robert George; Mansour,Marc; Pohajdak,Bill, Antigens for immunocontraception.
  15. Condon Thomas P. ; Flournoy Shin Cheng, Antisense modulation of ADAM10 expression.
  16. Brown, Robert; Pohajdak, Bill; Horrocks, Janet; McLaren, Leslie, Compositions and methods for reducing or preventing fertilization in fish and birds.
  17. Jager Elke,DEX ; Knuth Alexander,DEX, Compositions containing immunogenic molecules and granulocyte-macrophage colony stimulating factor, as an adjuvant.
  18. Dunbar Bonnie S. (2001 Holcombe #2302 Houston TX 77030) Prasad Sarvamangala V. (5123 Jackwood Houston TX 77096), Contraceptive vaccine comprising a glycosylated 55 kD zona pellucida protein immunogen and method of use of the same in.
  19. Dianwen,Ju; Tao,Qun; Ye,Dan, Cytokine gene modified antigen-presenting cell/tumor cell conjugate, its preparation and use.
  20. Dave S. B. Hoon ; Yasufumi Kaneda JP, DNA vaccine and methods for its use.
  21. Farrar Graham Henry,GBX ; Tinsley-Bown Anne Margaret,GBX ; Jones David Hugh,CAX, Encapsulation of bioactive agents.
  22. Farrar, Graham Henry; Tinsley-Bown, Anne Margaret; Jones, David Hughes, Encapsulation of bioactive agents.
  23. Graham Henry Farrar GB; Anne Margaret Tinsley-Brown GB; David Hugh Jones CA, Encapsulation of bioactive agents.
  24. Tarara,Thomas E.; Weers,Jeffry G.; Kabalnov,Alexey; Schutt,Ernest G.; Dellamary,Luis A., Engineered particles and methods of use.
  25. Brancq Bernard (Le Chesnay FRX) Trouve Grard (Castres FRX), Fluid vaccines and active principle vehicles containing a metabolizable oil.
  26. Duan, D. Roxanne; Ruben, Steven M., Follistatin-3.
  27. Dow Steve W. ; Elmslie Robyn E., Gene therapy for T cell regulation.
  28. Hosokawa Saiko,JPX ; Tagawa Toshiaki,JPX ; Hirakawa Yoko,JPX ; Ito Norihiko,JPX ; Nagaike Kazuhiro,JPX, Human monoclonal antibody specifically binding to surface antigen of cancer cell membrane.
  29. Wang Rong-Fu ; Rosenberg Steven A., Identification of TRP-2 as a human tumor antigen recognized by cytotoxic T lymphocytes.
  30. Cochrum Kent C. (Corte Madera CA) Stevenson Lynnor B. (Los Altos Hills CA) King Scott R. (San Francisco CA), Immunization implant and method.
  31. Alving Carl R. ; Muderhwa Jean M. ; Spitler Lynn E., Immunogenic compositions.
  32. Urban Robert G. ; Chicz Roman M. ; Collins Edward J. ; Hedley Mary Lynne, Immunogenic peptides from the HPV E7 protein.
  33. Cantrell John L. (Corvallis MT) Rudbach Jon A. (Hamilton MT), Immunological emulsion adjuvants for polysaccharide vaccines.
  34. Cantrell John L. (Corvallis MT), Immunological lipid emulsion adjuvant.
  35. Koelle,David M.; Hosken,Nancy A.; Posavad,Christine M.; Chen,Hongbo; McGowan,Patrick, Immunologically significant herpes simplex virus antigens and methods for using same.
  36. Marciani Dante J., Immunostimulating and vaccine compositions employing saponin analog adjuvants and uses thereof.
  37. Harvey Colin Manson,NZX, Injectable compositions.
  38. Rosey,Everett L., Lawsonia intracellularis proteins, and related methods and materials.
  39. Fountain Michael W. (Plainsboro NJ) Weiss Steven J. (Lawrenceville NJ) Kearns John J. (Princeton NJ) Weiner Alan L. (Plainsboro NJ) Popescu Mircea C. (Plainsboro NJ), Lipid matrix carriers for use in drug delivery systems.
  40. Kedar Eliezer,ILX ; Babai Ilan,ILX ; Barenholz Yechezkel,ILX, Liposomal influenza vaccine composition and method.
  41. Jonathan P. H. Wong CA, Liposome-encapsulated poly ICLC.
  42. Allen Theresa M. (Edmonton CA CAX) Gabizon Alberto (San Francisco CA), Liposomes with enhanced circulation time.
  43. Woodle Martin C. (Menlo Park CA) Martin Francis J. (San Francisco CA) Yau-Young Annie (Los Altos CA) Redemann Carl T. (Walnut Creek CA), Liposomes with enhanced circulation time.
  44. Domb Abraham J. (Baltimore MD), Liposphere carriers of vaccines.
  45. Chaux Pascal,BEX ; Stroobant Vincent,BEX ; Boon-Falleur Thierry,BEX ; van der Bruggen Pierre,BEX ; Thielemans Kris,BEX ; Kurthals Jurgen,BEX, Mage-3 peptides presented by HLA class II molecules.
  46. Kawakami Yutaka ; Rosenberg Steven A., Melanoma antigens and their use in diagnostic and therapeutic methods.
  47. Howard Sands ; Awadhesh Mishra CA, Method for administering camptothecins via injection of a pharmaceutical composition comprising microdroplets containing a camptothecin.
  48. Steiner, Mitchell S.; Raghow, Sharan, Method for chemoprevention of prostate cancer.
  49. Samuel John,CAX ; Kwon Glen, Method for eliciting Th1-specific immune response.
  50. Brayden,David J., Method for inducing a cell-mediated immune response and improved parenteral vaccine formulations thereof.
  51. Fernandez Julio M. ; Knudson Mark B., Method of delivering a lipid-coated condensed-phase microparticle composition.
  52. K?ndig, Thomas M.; Simard, John J. L., Method of inducing a CTL response.
  53. O'Hagan, Derek; Singh, Manmohan, Method of obtaining cellular immune responses from proteins.
  54. Brown Robert,CAX ; Mezei Michael,CAX ; Pohajdak Bill,CAX ; Kimmins Warwick Charles,CAX, Method to prevent fertilization in mammals by administering a single dose of zona pellucida derived antigens, liposome a.
  55. Brown Robert,CAX ; Mezei Michael,CAX ; Mezei Catherine,CAX ; Pohajdak Bill,CAX ; Kimmins Warwick Charles,CAX, Method to prevent fertilization in mammals by administering a single dose of zona pellucida derived antigens, liposome and adjuvant.
  56. Kubo Ralph T. ; Grey Howard M. ; Sette Alessandro ; Celis Esteban, Methods for making HLA binding peptides and their uses.
  57. Tarantino Ralph, Methods for the sustained release of biologically active compounds.
  58. Dominowski,Paul Joseph; Klose,Pamela K.; Krebs,Richard L.; Mannan,Ramasamy M., Microfluidized oil-in-water emulsions and vaccine compositions.
  59. Ghiso, Jorge; Vidal, Ruben; Frangione, Blas, Mutant genes in Familial British Dementia and Familial Danish Dementia.
  60. Mark Selby ; Christopher Walker, Nucleic acid immunization using a virus-based infection/transfection system.
  61. Brown Albert L. ; Dayalu Krishnaswamy Iyengar ; Kaufman Thomas James ; Newsham Rex Steven, Pasteurella haemolytica type A-1 bacterin-toxoid vaccine.
  62. Slingluff,Craig L.; Hunt,Donald F.; Shabanowitz,Jeffrey; Cox,Andrea L.; Engelhard,Victor H.; Kittlesen,David; Skipper,Jonathan; Hendrikson,Ronald C., Peptides recognized by melanoma-specific A1-, A2-and A3-restricted cytoxic lymphocytes, and uses therefor.
  63. Popescu Mircea C. ; Weiner Alan L. ; Recine Marie S. ; Janoff Andrew S. ; Estis Leonard ; Keyes Lynn D. ; Alving Carl R., Potentiation of immune responses with liposomal adjuvants.
  64. Munechika Koji (Osaka JPX) Seki Tomoyo (Osaka JPX) Kishi Norihide (Osaka JPX) Matsuda Hiroshi (Osaka JPX) Ueda Yasuo (Osaka JPX), Process for preparing liposome composition.
  65. Estrada Alberto (Saskatoon CAX) Redmond Mark J. (Saskatoon CAX) Laarveld Bernard (Saskatoon CAX), Quinoa saponin compositions and methods of use.
  66. Leveugle, Beatrice; Madiyalakan, Ragupathy; Noujaim, Antoine A.; Schultes, Birgit, Reagents and methods for inducing an immune response to prostate specific antigen.
  67. Edgar, John Alexander; Tahan, Khin Aye, Saponin adjuvant composition.
  68. O'Hagan, Derek; Singh, Manmohan, Stabilized protein particles for inducing cellular immune responses.
  69. Edwards, David A.; Hrkach, Jeffrey S., Stable spray-dried protein formulations.
  70. Boulikas, Teni, Therapy for human cancers using cisplatin and other drugs or genes encapsulated into liposomes.
  71. Alving Carl R. ; Glenn Gregory M., Transdermal delivery system for antigen.
  72. Haensler Jean,FRX, Use of a cationic amphipathic compound as a transfection agent, vaccine additive or drug.
  73. Anne Darbouret FR; Florence Brunel FR; Jorge Ronco FR, Use of an amphipathic compound for providing an adjuvant to a subunit vaccine.
  74. O'Hagan Derek ; Van Nest Gary ; Ott Gary S. ; Singh Manmohan, Use of microparticles combined with submicron oil-in-water emulsions.
  75. Barchfeld Gail L. ; Ott Gary ; Van Nest Gary A., Vaccine compositions containing liposomes.
  76. Alving Carl R. ; Owens Roberta R., Vaccine for induction of immunity to malaria.
  77. Gerber Jay D. (Lincoln NE), Vaccine formulation.
  78. Friede, Martin; Garcon, Nathalie; Gerard, Catherine Marie Ghislaine; Hermand, Philippe, Vaccines.
  79. Nathalie Garcon BE; Patricia Marie Christine Aline Francoise Momin BE, Vaccines.
  80. Brown, Robert George; Pohajdak, William; Kimmins, Warwick Charles, Vaccines with enhanced immune response and methods for their preparation.

이 특허를 인용한 특허 (1)

  1. Mansour, Marc; Karkada, Mohan; Weir, Genevieve Mary, Use of liposomes in a carrier comprising a continuous hydrophobic phase for delivery of polynucleotides in vivo.
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로